Warden Charles M 4
4 · OCULAR THERAPEUTIX, INC · Filed Jun 12, 2026
Research Summary
AI-generated summary of this filing
Ocular Therapeutix Director Charles M. Warden Receives RSU Award
What Happened
Charles M. Warden, a director of Ocular Therapeutix, was granted awards on June 10, 2026 totaling 58,000 shares/RSU-equivalents (14,000 shares and 44,000 derivative awards) at $0.00 per share (total reported cash consideration $0). The grants are awards (code A) under the company's 2021 Stock Incentive Plan and convert to common stock upon vesting.
Key Details
- Transaction date: June 10, 2026; Form 4 filed June 12, 2026 (timely; Form 4 due within two business days).
- Reported price: $0.00 per share; total cash paid reported as $0 (these are compensatory awards).
- Award amount: 14,000 shares + 44,000 derivative awards = 58,000 RSU-type awards.
- Vesting: Per footnotes, RSUs vest 100% on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders, subject to continued board service.
- Shares owned after transaction: not specified in the provided filing.
- Footnotes: F1 describes that each RSU represents a right to one share; F2 reiterates the 100% vesting-on-year-one schedule (applies to the reported awards).
- No sale or purchase on the open market—this is a compensation grant.
Context
These awards are typical director compensation and will convert to shares only upon vesting; they are not an immediate purchase or sale. Such grants compensate service and don't by themselves indicate a trading signal or change in insider sentiment.
Insider Transaction Report
- Award
Common Stock
[F1]2026-06-10+14,000→ 100,464 total - Award
Stock Option (Right to Buy)
[F2]2026-06-10+44,000→ 44,000 totalExercise: $8.74Exp: 2036-06-09→ Common Stock (44,000 underlying)
Footnotes (2)
- [F1]On June 10, 2026, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
- [F2]Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.